Discover why Nuumad has been recognised as a leading UK pharmacy technology company, earning multiple award shortlistings for innovation and clinical excellence. Learn how our PGD platform is helping pharmacies deliver safer, more efficient patient care.

What makes the best PGD platform for pharmacies? Explore how smarter technology improves consultation speed, safety, efficiency and patient care. Nuumad is redefining PGD delivery with faster workflows, intuitive technology, safer processes and pharmacist-led clinical decision making.

We're delighted to share that Nuumad has been named one of TechRound's HealthTech44 winners for 2026, ranking 16th on the list and placing us among the top 20 most exciting and innovative health technology companies recognised this year.

Across healthcare, financial pressure is pushing some organisations to return to paper-based Patient Group Directions (PGDs). On the surface, it looks like a sensible saving. But as Judit Mora, CEO and Co-Founder of Nuumad, argues, the hidden costs of manual processes can far outweigh the technology spend they replace.

Healthcare organisations are under growing pressure to scale services while managing rising operational and regulatory complexity. AI is increasingly positioned as the solution, particularly across pharmacies and frontline care settings. But in regulated healthcare environments, long-term success will depend less on how much AI organisations deploy and more on whether systems remain efficient, transparent, and sustainable to operate at scale. In this article, Nuumad CTO and Co-founder Nicholas Batten discusses how a stable approach can be achieved.

As funding pressures on the NHS grow, community pharmacies are reaching a turning point. What used to focus mainly on dispensing medicines is evolving into a more patient facing healthcare network. But this shift is not guaranteed. Without the right technology in place, pharmacies may struggle to keep up with rising demand, regulatory requirements, and increasingly complex patient needs.

The conversation around artificial intelligence (AI) has, to date, been dominated by hype. In healthcare particularly, this is problematic. Clinical environments are highly regulated systems where safety, traceability and accountability are non negotiables. The real opportunity, therefore, is not AI adoption, but understanding how intelligent systems, both probabilistic and deterministic, can be deployed responsibly to scale care without compromising compliance or cybersecurity.

On International Women’s Day, it’s tempting to post a message of support on your business socials quickly. Instead, why not consider more effective, longer-term action?

For women building businesses today, that work is often less about visibility and more about sustainability. It is about how we build, how we take risks and how we define success on our own terms. Much of the startup ecosystem still celebrates urgency. Move fast. Scale quickly. Raise early. Go all in. That narrative can be powerful but it is not universal, and it is not always the best option. Article written for Startups Magazine by Judit Mora, CEO of Nuumad

Health tech doesn’t need more code - it needs more empathy. At Nuumad, we’re using human centred design to turn fragmented pharmacy services into meaningful, continuous care.

Startup culture often celebrates speed, risk and all-in commitment. But in complex, regulated sectors, moving fast can be a liability rather than an advantage. Building gradually, alongside other work, can create better decisions, stronger trust and more sustainable growth. Slow beginnings, done with intent, often scale further.

As funding pressures on the NHS intensify, community pharmacies face a defining moment. Today, they must evolve through intelligent technology or risk obsolescence. The good news is that the tools to evolve are here and already operational. Artificial intelligence (AI) isn’t the existential threat some believe, it’s one of several technologies helping drive greater innovation, scalability, and resilience in pharmacy.

I spent my early career at some of London’s biggest healthcare agencies such as Langland, McCann, and Havas, helping brands communicate their value and connect with people. At Langland, I became a digital project manager and started working in UX with a larger technology team. I quickly realised my value wasn’t in speaking their language fluently, but in translating between worlds, connecting user empathy with technical precision. Listening became less about learning jargon and more about spotting patterns others missed. 

Independent pharmacies can mistakenly buy digital tools the same way they buy stock - price first, everything else later. Yet purchasing the wrong digital platform can lock in hidden costs for years. Borrow these six tried-and-tested checks from larger corporates to make a safer, faster decision. 

Independent pharmacies can mistakenly buy digital tools the same way they buy stock - price first, everything else later. Yet purchasing the wrong digital platform can lock in hidden costs for years. Borrow these six tried-and-tested checks from larger corporates to make a safer, faster decision.